Double-blind placebo-controlled phase 2 study to evaluate the safety & tolerability of PPS in subjects with MPS VILikeFollowShareSource: Giugliani, R. et. al.February 10, 2022Share your feedbackQuestions (0)Post questionYour question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.Start the conversationAsk Paradigm Biopharmaceuticals a question about this update.DiscoverShare your feedbackDiscover
